𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cross-clade T cell recognition of HIV.1

✍ Scribed by Frances Gotch


Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
647 KB
Volume
10
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

✦ Synopsis


Despite considerable advances in antiviral therapy for HIV infection, successful global intervention will require an effective vaccine. Current evidence suggests that cytotoxic T lymphocyte responses will be an important component of such vaccination. Recent evidence suggests that cytotoxic T lymphocytes raised against viral antigens from different clades (subtypes) of HIV.1 can cross-react extensively and such data have major implications for HIV vaccine design.


πŸ“œ SIMILAR VOLUMES


HIV-2 and T cell recognition
✍ Hilton C Whittle; Koya Ariyoshi; Sarah Rowland-Jones πŸ“‚ Article πŸ“… 1998 πŸ› Elsevier Science 🌐 English βš– 823 KB

HIV-2 is less pathogenic and less transmissible than HIV-1. Recent research in relation to deletions in the HIV nef gene and to immune cross-reactions between infections by HIV-2, HIV-1 and simian immunodeficiency virus suggests that T cell recognition and the control of viral replication may be mor

Dichotomy in cross-clade reactivity and
✍ Lisa A. Cavacini; Mark Duval; Ajay Patil; Charles Wood; Kenneth H. Mayer; Ruth M πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 156 KB

## Abstract The identification of broadly reactive and cross‐clade neutralizing antibodies will facilitate the development of a more universally effective vaccine for human immunodeficiency virus (HIV). Antibodies in sera from individuals infected with Clade B HIV bind native primary viral isolates